JPRN-UMIN000024426招募中未知
Effect of dipeptidyl peptidase 4 inhibitors on Glomerulotubular regulation of sodium balance and circadian blood pressure rhythm. - Na balance and BP rhythm during the treatment with DPP4 inhibitor.
agoya City University Graduate School of Medical Sciences Department of Cardio-Renal Medicine and Hypertension0 个研究点目标入组 60 人开始时间: 2016年10月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) GFR <30 30ml/min/1.73m2 or undergoing renal replacement therapy 2) severe ketosis, diabetic coma or pre-come 3) conditions with serious infection, perioperative period, and severe trauma 4) presence/possibility for pregnancy/lactation 5) GOT >100, or GPT >85 6) current treatment with insulin 7) any reason for ineligibility suggested by the attending doctor (history of allergic reaction to study medication)
研究者
相似试验
招募中
不适用
Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysisType 2 diabetic patients on hemodialysisJPRN-UMIN000006024Chibune general hospital5
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
尚未招募
不适用
The inhibitory effects of the DPP-4 inhibitor for progression of diabetic nephropathy, in the patients with type 2 diabetes in Japan.The CKD patients with type 2 diabetesJPRN-UMIN000011101Saitama Medical Center, Saitama Medical University50